NCT01344356
- Conditions
- Angiofibroma of Head and Neck, Carcinoma, Carcinoma, Squamous Cell, +24 more
- Locations
-
- St. John's Mercy Medical Center St Louis, Missouri, United States
Clinical trial condition
Salivary Gland Cancer
Explore clinical trials studying Salivary Gland Cancer. Study availability and eligibility vary by location and protocol.
31 public trials
8 recruiting studies
Salivary Gland Cancer trial results
Completed
PSMA-PET Imaging for Advanced ACC/SDC
NCT03319641
- Conditions
- Adenocarcinoma, Adenoid Cystic Carcinoma, Carcinoma, +13 more
- Locations
-
- Radboudumc Nijmegen, Gelderland, Netherlands
NCT00509002
- Conditions
- Head and Neck Neoplasms, Mouth Diseases, Mouth Neoplasms, +6 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
Completed
A Study of Sunitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands
NCT00886132
- Conditions
- Adenocarcinoma, Adenoid Cystic Carcinoma, Carcinoma, +18 more
- Locations
-
- Princess Margaret Hospital Toronto, Ontario, Canada
Active, Not Recruiting
APG-115 in Salivary Gland Cancer Trial
NCT03781986
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Adenoid Cystic, +12 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
- University of Chicago Chicago, Illinois, United States
- University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States
Active, Not Recruiting
Amivantamab in Adenoid Cystic Carcinoma
NCT05074940
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Adenoid Cystic, +11 more
- Locations
-
- UC San Diego Moores Cancer Center La Jolla, California, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Rogel Cancer Center - University of Michigan Health Ann Arbor, Michigan, United States
- Washington University - School of Medicine in St. Louis St Louis, Missouri, United States
Active, Not Recruiting
Pembrolizumab With Chemotherapy for Poorly Chemo-responsive Thyroid and Salivary Gland Tumors
NCT03360890
- Conditions
- Endocrine Gland Neoplasms, Endocrine System Diseases, Head and Neck Neoplasms, +11 more
- Locations
-
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
Active, Not Recruiting
Lenvatinib and Pembrolizumab in People With Advanced Adenoid Cystic Carcinoma and Other Salivary Gland Cancers
NCT04209660
- Conditions
- Adenocarcinoma, Adenoid Cystic Carcinoma, Carcinoma, +12 more
- Locations
-
- Baptist Alliance MCI Miami, Florida, United States
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (All protocol activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
Active, Not Recruiting
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)
NCT02628067
- Conditions
- Adenocarcinoma, Adenoma, Advanced Cancer, +88 more
- Locations
-
Not specified
Active, Not Recruiting
9-ING-41 Plus Carboplatin in Salivary Gland Carcinoma
NCT05010629
- Conditions
- Adenocarcinoma, Adenoid Cystic Carcinoma, Carcinoma, +18 more
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States